Skip to main content

Table 1 The distribution of anticentromere antibody-positive patients according to anti-cyclic citrullinated peptide results

From: The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients

 

Anticentromere antibody-positive (n= 81)a

 
 

Anti-CCP positive (n= 29)b

Anti-CCP negative (n= 52)

P-valuec

RA

24

10

< 0.05

   with Raynaud

0/24

1/10

0.116

   with sicca

2/24

0/10

0.347

   with IPD

3/24

1/10

0.837

Other diseasesd

5

42

 
  1. aAnticentromere detected by autoimmune target (AIT) test (ImmunoThink Co., Seoul, Republic of Korea). bAnti-CCP detected by second generation ELISA (Axis-Shield, Dundee Scotland/Immco Diagnostics, Buffalo, USA). cChi-square test (P < 0.05). dOther diseases include systemic sclerosis, systemic lupus erythematosus, Raynaud's phenomenon, Sjögren's syndrome, unspecified rheumatism and osteoarthritis. CCP, cyclic citrullinated peptide; IPD, interstitial pulmonary disease; RA, rheumatoid arthritis.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us